Skip to main content
Earnings Labs
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ·Healthcare·Biotechnology

$2.93

+2.27%

Mkt Cap $163.55M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (1 analysts)

$7.00

Range $7.00$7.00

Implied Upside

+139.3%

Consensus $7.00 vs current $2.93